Ubenimex enhances the antitumor effect of anti PD-1 antibody, regardless of the sensitivity of anti PD-1 antibody

被引：0
|
作者：
Igo, Naoko [1 ]
Nagai, Daichi [1 ]
Otake, Katsumasa [1 ]
Tomura, Arihiro [1 ]
Ichimura, Eiji [1 ]
Yokoyama, Hirofumi [1 ]
机构：
[1] Nippon Kayaku Co Ltd, Pharm Res Lab, Tokyo, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2191
引用
收藏
页码：1178 / 1178
页数：1
相关论文
共 50 条
  • [11] An Anti-Programmed Death-1 Antibody (αPD-1) Fusion Protein That Self-Assembles into a Multivalent and Functional αPD-1 Nanoparticle
    Zhao, Peng
    Atanackovic, Djordje
    Dong, Shuyun
    Yagita, Hideo
    He, Xiao
    Chen, Mingnan
    MOLECULAR PHARMACEUTICS, 2017, 14 (05) : 1494 - 1500
  • [12] Expression and clinical significance of PD-1 in hepatocellular carcinoma tissues detected by a novel mouse anti-human PD-1 monoclonal antibody
    Li, Ziwei
    Li, Bin
    Peng, Dan
    Xing, Haiyan
    Wang, Guanying
    Li, Pan
    Wang, Jiming
    Ye, George
    Chen, Jianhong
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (06) : 2079 - 2092
  • [13] The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling
    Tianye Li
    Mengke Niu
    Jianwei Zhou
    Kongming Wu
    Ming Yi
    Cell Communication and Signaling, 22
  • [14] The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling
    Li, Tianye
    Niu, Mengke
    Zhou, Jianwei
    Wu, Kongming
    Yi, Ming
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [15] Anti-PD-L1 DNA aptamer antagonizes the interaction of PD-1/PD-L1 with antitumor effect
    Gao, Tian
    Mao, Zheng
    Li, Wenjing
    Pei, Renjun
    JOURNAL OF MATERIALS CHEMISTRY B, 2021, 9 (03) : 746 - 756
  • [16] Detection of Activated PD-1: Generation of an Antibody Against the PD-1 Phospho-ITSM
    Sham, Caroline
    Chan, Ann
    Yang, Nancy
    Gordon, Lynn
    Braun, Jonathan
    CLINICAL IMMUNOLOGY, 2009, 131 : S139 - S139
  • [17] Development and prospects of a new anti-cancer agent ∼ the first anti PD-1 antibody in the world ∼
    Nanba, Yoshinobu
    ANNALS OF ONCOLOGY, 2015, 26 : 22 - 22
  • [18] Toripalimab: A Next Generation Designed Anti -PD-1 Antibody for Treatment of Nasopharyngeal Carcinoma
    Rajasekaran, N.
    Ravindranathan, S.
    Wang, X.
    Chin, D. J.
    Tseng, S. Y.
    Klakamp, S.
    Widmann, K.
    Young, G.
    Yu, B.
    Kapoor, V.
    Vexler, V.
    Keegan, P.
    Yao, S.
    Khare, S. D.
    LaVallee, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : E88 - E89
  • [19] Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer
    Janice M. Mehnert
    Andrea Varga
    Marcia S. Brose
    Rahul R. Aggarwal
    Chia-Chi Lin
    Amy Prawira
    Filippo de Braud
    Kenji Tamura
    Toshihiko Doi
    Sarina A. Piha-Paul
    Jill Gilbert
    Sanatan Saraf
    Pradeep Thanigaimani
    Jonathan D. Cheng
    Bhumsuk Keam
    BMC Cancer, 19
  • [20] Anti PD-1 Antibody Therapy in a Pediatric Case of Primary Intracranial Malignant Melanoma
    Oba, Utako
    Koga, Yuhki
    Kawaguchi, Riichiro
    Nakashima, Kentaro
    Ishimura, Masataka
    Akagi, Yojiro
    Hata, Nobuhiro
    Yoshimoto, Koji
    Kohashi, Kenichi
    Iihara, Koji
    Oda, Yoshinao
    Ohga, Shouichi
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S94 - S95
12345